MedBen Rx
  • About Us
  • Genomic Testing
  • Resources
    • MedBen Rx Blog
    • Online Services & Forms
  • Contact Us
  • MedBen Access
  • MedBen.com
Select Page

JPMorgan Sued for Allowing Inflated Drug Prices through its PBM

Mar 24, 2025 | Drug costs, Lawsuits, News, Pharmacy Benefits Manager (PBM), Prescription drugs, Rx Costs

Current and former employees are suing the financial services firm JPMorgan for allowing inflated drug prices through its partnership with pharmacy benefits manager (PBM) CVS Caremark. The plaintiffs claim that poor PBM oversight led to unnecessarily high prescription...

Prepping for the 2025 Health Care Cost Forecast

Oct 29, 2024 | Client Report, Cost projections, Cost Savings, Drug costs, MedBen Rx, Prescription drugs, Rx Costs, Transparency, Trend

Health care costs in the United States are projected to see their steepest rise in over a decade during 2025, with multiple industry analyses forecasting increases between 7% and 8% year-over-year (see table below). However, MedBen offers solutions that directly...

Humira Biosimilar Program Sees Over $3 Million in Annualized Client Savings

Apr 16, 2024 | Biosimilar, Cost Savings, Drug costs, Humira, Idacio, Prescription drugs, Rx Costs, Savings

Last year, MedBen Rx announced a new program that would enable clients to purchase Idacio, a biosimilar version of the anti-inflammatory therapy Humira – a drug that typically costs between $6,000 and $12,000 per month depending on the dose – for under $1,000 per...

Tackle Specialty Drugs with MedBen Rx’s Benefit Preservation Program

Jan 22, 2024 | Access solutions, Benefits preservation, MedBen Rx, Pharmacies, Prescription drugs, Specialty Drugs

A recent Segal Health Plan Cost Trend Survey projects 2024 cost trend for prescription drugs to approach 10%… but specialty drug trend alone may reach 15% this year, as increased use of expensive drugs continues to drive costs up. (We’ve actually seen...

ACI Drug Pricing Beats the PBM “Spread”

Dec 22, 2023 | Acquisition Cost Index (ACI), Cost Plus Pricing, Cost Savings, Drug costs, MedBen Rx, Pharmacies, Prescription drugs, Rx Costs, Savings, Spread Pricing

Spread pricing is the difference between what pharmacy benefit managers (PBMs) charge health plans for drugs and what the pharmacy actually pays for them. Often, this “spread” can be substantial, as PBMs profit greatly from their lack of transparency… so it’s not...

A High-Value Approach to Lowering Rx Spend

Oct 30, 2023 | Appropriateness Solutions, Comparative Effectiveness, Drug costs, MedBen Rx, Pharmacies, Prescription drugs, Research

MedBen Rx’s expanded pharmacy solutions offer a variety of ways to reduce your prescription drug spend… including appropriateness solutions that use clinical-based research to recommend the most effective drugs to your plan members. Comparative...
« Older Entries

Categories

  • 340B
  • Access solution
  • Access solutions
  • Acquisition Cost Index (ACI)
  • Affordable Care Act
  • Anniversaries
  • Announcements
  • Appropriateness Solutions
  • Avande
  • Average Wholesale Price
  • Benefits Advisory Conference
  • Benefits preservation
  • Biologics
  • Biosimilar
  • Brand Name Drugs
  • Brian Fargus
  • Cancer
  • Caroline Fraker
  • Case Study
  • Cholesterol
  • Claims
  • Client Report
  • Comparative Effectiveness
  • Compliance
  • Consolidated Appropriations Act of 2021 (CAA)
  • Cost Plus
  • Cost Plus Pricing
  • Cost projections
  • Cost Savings
  • Diabetes
  • Discounts
  • Doug Freeman
  • Drug costs
  • Drug makers
  • Drug marketing
  • Drug reimportation
  • Evidence-based research
  • Federal Trade Commission (FTC)
  • Food and Drug Administration (FDA)
  • Formularies
  • Fraud
  • Gene therapy
  • Generic Drugs
  • Genetic testing
  • Genomics
  • GLP-1s
  • Government
  • Guarantees
  • Health and Human Services
  • Health systems
  • Heart medications
  • History
  • Humalog
  • Humira
  • Idacio
  • Inflation
  • Kurt Harden
  • Lawsuits
  • Legislation
  • Limited Use HRA
  • Lobbying
  • Luke Burchard
  • MDMA (ecstasy)
  • MedBen
  • MedBen Access
  • MedBen Basics
  • MedBen Board of Directors\
  • MedBen employees
  • MedBen Rx
  • MedBen Rx Advocate
  • MedBen Rx Alliance
  • MedBen Rx News
  • MedBen University
  • Medicare
  • Mobile app
  • Mounjaro
  • News
  • Nutrigenomics
  • Online Services
  • Opinions
  • Outcomes
  • Overprescribing
  • Own Use
  • Ozempic
  • Patient advocacy program
  • Perigon Pharmacy 360
  • Pharmacies
  • Pharmacogenomics
  • Pharmacy Benefits Manager (PBM)
  • Pharmacy Services Administrator (PSA)
  • Precision medicine
  • Prescription drugs
  • Prescription Portal
  • Pricing solutions
  • Psychedelic drugs
  • Rebates
  • Regulatory
  • Reporting
  • Research
  • Rx Advertising
  • Rx Costs
  • Rx Facts
  • Rx prices
  • Rx Spending
  • RxDC report
  • Savings
  • Specialty Drugs
  • Spread Pricing
  • State legislation
  • Statins
  • Stelara
  • Study
  • Surveys
  • Transparency
  • Trend
  • TruDataRx
  • Trulicity
  • Value
  • Ventegra
  • Wegovy
  • Weight loss
  • Weight loss drugs
  • Weight management
  • Wellness
  • White paper
  • Zepbound
  • About Us
  • Contact Us
  • Blog
  • Online Services
  • MedBen Access
  • Sitemap
  • Privacy
  • MedBen.com

Sign Up for our Newsletter

  • This field is for validation purposes and should be left unchanged.
© 2025 MedBen Rx. All rights reserved.